Pros | ![]() Lower expense ratio. ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() 5Y returns in the top 25% of the category. ![]() 3Y returns in the top 25% of the category. ![]() Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | - |
INDMoney rank | 5/8 | 1/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 6 Years | 12 Years | ||
Fund Size | 2441 Cr | 3313 Cr | ||
Min Investment | SIP ₹99 Lumpsum ₹5000 | SIP ₹500 Lumpsum ₹5000 | ||
Expense Ratio | 0.52% | 0.97% | ||
Exit Load | 1% | 0.5% | ||
Benchmark Index | S&P BSE Healthcare PR | S&P BSE Healthcare PR |
No of Holdings | 34 | 32 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (11.84%) Cipla Ltd (7.6%) Aurobindo Pharma Ltd (7.09%) Divi's Laboratories Ltd (6.53%) Lupin Ltd (6.36%) | Sun Pharmaceuticals Industries Ltd (13.47%) Max Healthcare Institute Ltd Ordinary Shares (6.5%) Divi's Laboratories Ltd (6.2%) Cipla Ltd (5.1%) Lonza Group Ltd ADR (5%) | ||
No of Sectors | 3 | 3 | ||
Top 3 Sectors | Health (98.63%) Basic Materials (0.86%) Industrial (0.51%) | Health (92.92%) Basic Materials (7.08%) Government (3.05%) | ||
Equity % | 99.6% | 97.29% | ||
Debt % | - | 0.09% | ||
P/E | 33.85 | 42.21 | ||
P/B | 4.98 | 5.85 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 9.16% | 7.6% | ||
3-Month Return | -6.02% | -4.37% | ||
6-Month Return | -6.42% | -1.51% | ||
1-Year Return | 18.97% | 21.25% | ||
3-Year Return | 19.77% | 24.58% | ||
5-Year Return | 30.98% | 31.9% |
Sharpe | 0.69 | 1.06 | ||
Alpha | -0.39 | 5.04 | ||
Beta | 0.97 | 0.85 | ||
Standard Deviation | 16.65 | 14.61 | ||
Information Ratio | -0.26 | 1.06 |
Description | Mirae Asset Healthcare Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | SBI Healthcare Opportunities Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Vrijesh Kasera | Tanmaya Desai |